venBio Partners LLC Q4 2024 Filing
Filed February 14, 2025
Portfolio Value
$170.7B
Holdings
7
Report Date
Q4 2024
Filing Type
13F-HR
All Holdings (7 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | PHVSPHARVARIS N V | 4,289,304 | $82.2B | 48.17% | |
| 2 | ALMSALUMIS INC | 2,787,398 | $21.9B | 12.83% | |
| 3 | HRMYHARMONY BIOSCIENCES HLDGS IN | 539,194 | $18.6B | 10.87% | |
| 4 | ALXOALX ONCOLOGY HLDGS INC | 9,699,925 | $16.2B | 9.49% | |
| 5 | ARTVARTIVA BIOTHERAPEUTICS INC | 1,519,971 | $15.3B | 8.98% | |
| 6 | SLRNACELYRIN INC | 3,806,410 | $12.0B | 7.00% | |
| 7 | LYELLYELL IMMUNOPHARMA INC | 7,102,190 | $4.5B | 2.66% |